| |
| |
|
|
|
|
|
2008 |
|
|
2007 |
|
| |
|
|
|
|
|
R million |
|
|
R million |
|
| |
 |
|
Notes |
|
|
(Reviewed) |
|
|
(Audited) |
|
| Share capital and premium |
 |
|
|
|
|
|
|
|
|
|
| Balance at the beginning of the year |
|
|
|
|
|
90,8 |
|
|
76,9 |
|
| Issue of shares |
|
|
|
|
|
16,1 |
|
|
14,0 |
|
| Shares cancelled in terms of buy-back of treasury shares-capital portion |
|
|
|
|
|
— |
|
|
(0,1) |
|
| Balance at the end of the year |
|
|
|
|
|
106,9 |
|
|
90,8 |
|
| Share-based payment reserve |
|
|
|
|
|
|
|
|
|
|
| Balance at the beginning of the year |
|
|
|
|
|
649,9 |
|
|
40,4 |
|
| Share-based payment expense |
|
|
|
|
|
14,4 |
|
|
607,4 |
|
| Contribution by Reunert to employees of joint venture and associate in terms of |
|
|
|
|
|
|
|
|
|
|
| broad-based scheme |
|
|
|
|
|
— |
|
|
2,1 |
|
| Balance at the end of the year |
|
|
|
|
|
664,3 |
|
|
649,9 |
|
| Fair value adjustment reserve* |
|
|
|
|
|
|
|
|
|
|
| Balance at the beginning of the year |
|
|
|
|
|
— |
|
|
— |
|
| Arising on fair valuation of financial instruments |
|
|
7 |
|
|
660,3 |
|
|
— |
|
| Deferred taxation on fair value gain |
|
|
|
|
|
(39,2) |
|
|
— |
|
| Balance at the end of the year |
|
|
|
|
|
621,1 |
|
|
— |
|
| Equity transaction with BEE partner |
|
|
|
|
|
|
|
|
|
|
| Balance at the beginning of the year |
|
|
|
|
|
— |
|
|
— |
|
| Purchase of a portion of BEEs interest in a subsidiary not previously recognised as |
|
|
|
|
|
|
|
|
|
|
| a minority |
|
|
8 |
|
|
(35,3) |
|
|
— |
|
| Balance at the end of the year |
|
|
|
|
|
(35,3) |
|
|
— |
|
| Treasury shares |
|
|
|
|
|
|
|
|
|
|
| Balance at the beginning of the year |
|
|
9 |
|
|
(276,1) |
|
|
(282,0) |
|
| Shares cancelled in terms of buy-back of treasury shares – capital portion |
|
|
|
|
|
— |
|
|
0,1 |
|
| Shares cancelled in terms of buy-back of treasury shares – dividend portion |
|
|
|
|
|
— |
|
|
5,8 |
|
| Balance at the end of the year |
|
|
|
|
|
(276,1) |
|
|
(276,1) |
|
| Non-distributable reserves |
|
|
|
|
|
|
|
|
|
|
| Balance at the beginning of the year – restated** |
|
|
|
|
|
7,3 |
|
|
3,7 |
|
| Balance at the beginning of the year – as previously reported |
|
|
|
|
|
— |
|
|
104,8 |
|
| Share of associate company’ s retained earnings at the beginning of the year transferred |
|
|
|
|
|
|
|
|
|
|
| to retained earnings |
|
|
|
|
|
— |
|
|
(101,1) |
|
| Translation reserve |
|
|
|
|
|
0,7 |
|
|
(0,3) |
|
| Reunert’ s share of previously equity-accounted associate’s actuarially valued |
|
|
|
|
|
|
|
|
|
|
| of medical aid provision*** |
|
|
|
|
|
(3,9) |
|
|
3,9 |
|
| Balance at the end of the year |
|
|
|
|
|
4,1 |
|
|
7,3 |
|
| Retained earnings |
|
|
|
|
|
|
|
|
|
|
| Balance at the beginning of the year
– restated** |
|
|
|
|
|
1 997,1 |
|
|
1 841,9 |
|
| Balance at the beginning of the year – as previously reported |
|
|
|
|
|
1 997,1 |
|
|
1 740,8 |
|
| Share of associate company’ s retained earnings at the beginning of the year transferred |
|
|
|
|
|
|
|
|
|
|
| from non-distributable reserves |
|
|
|
|
|
— |
|
|
101,1 |
|
| Profit for the year |
|
|
|
|
|
1 156,6 |
|
|
639,3 |
|
| Reunert’ s share of previously equity-accounted associate’s actuarially valued |
|
|
|
|
|
|
|
|
|
|
| of medical aid provision transferred from non-distributable reserves*** |
|
|
|
|
|
3,9 |
|
|
— |
|
| Cash dividends declared and paid |
|
|
|
|
|
(567,2) |
|
|
(478,3) |
|
| Shares cancelled in terms of buy-back of treasury shares – dividend portion |
|
|
|
|
|
— |
|
|
(5,8) |
|
| Balance at the end of the year |
|
|
|
|
|
2 590,4 |
|
|
1 997,1 |
|
| Equity attributable to equity holders of Reunert Limited |
|
|
|
|
|
3 675,4 |
|
|
2 469,0 |
|
| Minority interest |
|
|
|
|
|
|
|
|
|
|
| Balance at the beginning of the year |
|
|
|
|
|
14,4 |
|
|
38,2 |
|
| Profit for the year |
|
|
|
|
|
7,1 |
|
|
7,6 |
|
| Dividends declared and paid |
|
|
|
|
|
(1,8) |
|
|
(4,5) |
|
| Net movement in minorities |
|
|
|
|
|
1,0 |
|
|
(26,9) |
|
| Balance at the end of the year |
|
|
|
|
|
20,7 |
|
|
14,4 |
|
| Total equity at the end of the year |
|
|
|
|
|
3 696,1 |
|
|
2 483,4 |
|
|
|